ライフサイエンスコーパス: magnetic resonance spectroscopy

1 as measured by ex vivo (1)H-[(13)C]-nuclear magnetic resonance spectroscopy.

2 equential (2)H and (31)P solid-state nuclear magnetic resonance spectroscopy.

3 ned using (1)H and (7)Li solid-state nuclear magnetic resonance spectroscopy.

4 by using in vivo saturation transfer [(31)P]-magnetic resonance spectroscopy.

5 ometry, tandem mass spectrometry and nuclear magnetic resonance spectroscopy.

6 We measured GlycA by nuclear magnetic resonance spectroscopy.

7 ams, vibrational spectroscopies, and nuclear magnetic resonance spectroscopy.

8 sment and liver fat content quantified using Magnetic Resonance Spectroscopy.

9 d after ketamine administration using proton magnetic resonance spectroscopy.

10 in vitro and on protein structure by Nuclear Magnetic Resonance spectroscopy.

11 e measured by quantitative deuterium nuclear magnetic resonance spectroscopy.

12 0% (P<0.04) increase in IMCL, assessed by 1H magnetic resonance spectroscopy.

13 chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy.

14 rs were observed through solid-state nuclear magnetic resonance spectroscopy.

15 d plasma was undertaken using proton nuclear magnetic resonance spectroscopy.

16 nic phosphate concentrations with (1)H/(31)P magnetic resonance spectroscopy.

17 c action in obese fat-1 mice, as revealed by magnetic resonance spectroscopy.

18 19 AD, 19 MCI, and 28 HC with in vivo proton magnetic resonance spectroscopy.

19 resolution, which is validated using nuclear magnetic resonance spectroscopy.

20 striatum were assessed using 3-Tesla proton magnetic resonance spectroscopy.

21 for 10 d and had liver fat (LF) measured by magnetic resonance spectroscopy.

22 ing solid-state magic angle spinning nuclear magnetic resonance spectroscopy.

23 ntrations of neurometabolites measured using magnetic resonance spectroscopy.

24 imaging; IHCL was assessed by in vivo proton magnetic resonance spectroscopy.

25 could not be detected in solution by nuclear magnetic resonance spectroscopy.

26 oughput mass spectrometry and proton nuclear magnetic resonance spectroscopy.

27 agnitude higher sensitivity compared to (1)H magnetic resonance spectroscopy.

28 igh resolution mass spectrometry and nuclear magnetic resonance spectroscopy.

29 c ligand and loop interactions using nuclear magnetic resonance spectroscopy.

30 vivo lowered Glu levels as measured by (1)H magnetic resonance spectroscopy.

31 ulating amino acids were assessed by nuclear magnetic resonance spectroscopy.

32 electron paramagnetic resonance, and nuclear magnetic resonance spectroscopy.

33 ssed with the use of high-throughput nuclear magnetic resonance spectroscopy.

34 try and lipidome analysis using (1)H nuclear magnetic resonance spectroscopy.

35 ate of glutamate and glutamine) levels using magnetic resonance spectroscopy.

36 ortical nuclei/regions with 1.5-tesla proton magnetic resonance spectroscopy.

37 re compared via 4-tesla proton single volume magnetic resonance spectroscopy.

38 determinants that are identified by nuclear magnetic resonance spectroscopy.

39 lion times greater than those of traditional magnetic resonance spectroscopies.

40 niques, including far-infrared, optical, and magnetic resonance spectroscopies.

41 oholic fatty liver disease (NAFLD) by proton magnetic resonance spectroscopy ((1) H-MRS) was establis

42 tic triglyceride content (IHTG) using proton magnetic resonance spectroscopy ((1) H-MRS), abdominal f

43 netic resonance imaging (rs-fMRI) and proton magnetic resonance spectroscopy ((1)H MRS) were performe

44 C)) in bipolar disorder using in vivo proton magnetic resonance spectroscopy ((1)H MRS), especially i

45 and 20 mg/L) was evaluated by proton nuclear magnetic resonance spectroscopy ((1)H NMR) and gas chrom

46 Nuclear magnetic resonance spectroscopy ((1)H NMR) was used to m

47 Nuclear magnetic resonance spectroscopy ((1)H, (13)C, and (31)P)

48 we address this need by presenting a proton magnetic resonance spectroscopy ((1)H-MRS) acquisition s

49 fat can be non-invasively measured by proton magnetic resonance spectroscopy ((1)H-MRS) and fibrosis

50 l muscle as measured by using in vivo proton magnetic resonance spectroscopy ((1)H-MRS) and whether t

51 roop task and single-voxel J-resolved proton magnetic resonance spectroscopy ((1)H-MRS) in the rACC t

52 on density fat fraction (PDFF), using proton magnetic resonance spectroscopy ((1)H-MRS), instead of c

53 and healthy full-term newborns using proton magnetic resonance spectroscopy ((1)H-MRS).

54 We measured: (1) liver fat by proton magnetic resonance spectroscopy ((1)H-MRS); (2) severity

55 n of hyperpolarized H(13)CO3(-), using (13)C-magnetic resonance spectroscopy ((13)C-MRS) magnetizatio

56 tored in these cells by hyperpolarized (13)C-magnetic resonance spectroscopy ((13)C-MRS), which revea

57 Using proton magnetic resonance spectroscopy (1H MRS), this study ass

58 igated the use of long-echo time (TE) proton magnetic resonance spectroscopy (1H-MRS) to measure skel

59 tic glutamate, can be quantified with proton magnetic resonance spectroscopy (1H-MRS).

60 the identification of InsP(n), (31)P nuclear magnetic resonance spectroscopy ((31)P NMR).

61 Phosphorus magnetic resonance spectroscopy ((31)P-MRS), in particul

62 ontent [HCL]) were measured with multinuclei magnetic resonance spectroscopy ((31)P/(1)H-MRS).

63 he brain of male volunteers using phosphorus magnetic resonance spectroscopy ((31)PMRS) and to compar

64 Phosphorus-31 magnetic resonance spectroscopy (31P MRS) allows for the

65 usion tensor imaging with diffusion-weighted magnetic resonance spectroscopy, a powerful tool capable

66 and changes in chemical shifts from nuclear magnetic resonance spectroscopy also support the above r

67 noassay, and LDL-P was measured with nuclear magnetic resonance spectroscopy among 27 533 healthy wom

68 ever, Fourier transform infrared and nuclear magnetic resonance spectroscopy analyses showed that its

69 sex-matched healthy controls, using nuclear magnetic resonance spectroscopy and a validated ex vivo

70 icle concentrations were measured by nuclear magnetic resonance spectroscopy and categorized into 5 s

71 Here we show, using nuclear magnetic resonance spectroscopy and density functional t

72 1)P solid-state magic-angle-spinning nuclear magnetic resonance spectroscopy and differential scannin

73 ent in vivo hyperpolarized [1-(13)C]pyruvate magnetic resonance spectroscopy and echocardiography to

74 te or (13)C-oleate for dynamic (13)C nuclear magnetic resonance spectroscopy and end point liquid chr

75 ls and in stroke-affected C57-BL6 mice using magnetic resonance spectroscopy and GC-MS.

76 of nuclear spins is a primary limitation of magnetic resonance spectroscopy and imaging.

77 VAT, and subcutaneous fat were determined by magnetic resonance spectroscopy and imaging.

78 e of low-temperature rapid injection nuclear magnetic resonance spectroscopy and kinetic studies to g

79 iglyceride contents were measured with 1.5 T magnetic resonance spectroscopy and LV function, viscera

80 Nuclear magnetic resonance spectroscopy and magnetic resonance i

81 GCG was carefully characterized with nuclear magnetic resonance spectroscopy and mass spectrometry.

82 s, Isothermal Titration Calorimetry, Nuclear Magnetic Resonance spectroscopy and molecular modeling.

83 limb of the internal capsule, measured with magnetic resonance spectroscopy and MRI, respectively, w

84 studies of human biospecimens to the use of magnetic resonance spectroscopy and novel mouse models,

85 n relative to alternative techniques such as magnetic resonance spectroscopy and positron emission to

86 All subjects underwent magnetic resonance spectroscopy and q-space imaging of t

87 tests, we explored the potential for spinal magnetic resonance spectroscopy and q-space imaging to d

88 maging techniques, such as single-voxel (1)H-magnetic resonance spectroscopy and q-space imaging, hav

89 MDAR hypofunction affects the brain, we used magnetic resonance spectroscopy and resting-state functi

90 ave characterized the interaction by nuclear magnetic resonance spectroscopy and show that it is exte

91 rescence cell wall using solid-state nuclear magnetic resonance spectroscopy and small-angle neutron

92 ng factor U2AF65 using complementary nuclear magnetic resonance spectroscopy and small-angle scatteri

93 ed [U-2H, U-13C]glucose to lactate using 13C magnetic resonance spectroscopy and spectroscopic imagin

94 Nuclear magnetic resonance spectroscopy and thioacidolysis revea

95 cts were analysed using 600 MHz (1)H Nuclear Magnetic Resonance spectroscopy and Ultra-Performance Li

96 ticles formation is elucidated using nuclear magnetic resonance spectroscopy and with molecular dynam

97 entrations and size were measured by nuclear magnetic resonance spectroscopy, and apolipoproteins wer

98 rpolarized in vivo pyruvate studies, nuclear magnetic resonance spectroscopy, and carbon-13 feeding s

99 agenesis, surface plasmon resonance, nuclear magnetic resonance spectroscopy, and cross-linking and m

100 mined cerebral energy consumption with (31)P magnetic resonance spectroscopy, and determined systemic

101 Using positron emission tomography, magnetic resonance spectroscopy, and electroencephalogra

102 ephalography, magnetoencephalography, proton magnetic resonance spectroscopy, and functional magnetic

103 use biochemistry, mass spectrometry, nuclear magnetic resonance spectroscopy, and genetic analyses to

104 ins using microscale thermophoresis, nuclear magnetic resonance spectroscopy, and isothermal titratio

105 tional photophysical investigations, nuclear magnetic resonance spectroscopy, and kinetic studies to

106 Raman spectroscopy, (15)N and (31)P nuclear magnetic resonance spectroscopy, and mass spectrometry.

107 e, using vibrational and solid-state nuclear magnetic resonance spectroscopy, and molecular dynamics

108 aman spectroscopy, (27)Al and (35)Cl nuclear magnetic resonance spectroscopy, and pair distribution f

109 ion, local concentrations of basal GABA with magnetic resonance spectroscopy, and RT with a behaviora

110 Current mass spectrometry, nuclear magnetic resonance spectroscopy, and X-ray diffraction a

111 Using a novel 31P magnetization transfer magnetic resonance spectroscopy approach, we provide dir

112 New advances in nuclear imaging and magnetic resonance spectroscopy are showing that they ha

113 ucidated using mass spectrometry and nuclear magnetic resonance spectroscopy as 2-heptyl-2-hydroxy-1,

114 constant using (31)P magnetization transfer magnetic resonance spectroscopy as described previously.

115 identified by mass spectrometry and nuclear magnetic resonance spectroscopy as monoglucosyl diacylgl

116 nection with chemical shifts of (1)H nuclear magnetic resonance spectroscopy, as they can exhibit val

117 were cognitively assessed and underwent (1)H-magnetic resonance spectroscopy at 3 T to assess glutama

118 MEscher-GArwood Point RESolved Spectroscopy) magnetic resonance spectroscopy at 3 T, to quantify gamm

119 timulation in the occipital lobe using (31)P magnetic resonance spectroscopy at 4T.

120 late cortex at 1 and 24 h post infusion with magnetic resonance spectroscopy at 7 T.

121 Proton magnetic resonance spectroscopy at 7T was performed in 2

122 in patients with schizophrenia using proton magnetic resonance spectroscopy at 7T, which allows sepa

123 We perform (1)H and (19)F nuclear magnetic resonance spectroscopy at room temperature in m

124 With the use of a (1)H nuclear magnetic resonance spectroscopy-based metabolic profilin

125 umans was measured using ultra-high-field 7T magnetic resonance spectroscopy before and after short-t

126 ar lipids (HCLs)] with the use of (31)P/(1)H magnetic resonance spectroscopy before and at 160 and 24

127 yzed using in vivo 13C/31P/1H and ex vivo 2H magnetic resonance spectroscopy before and during hyperi

128 sphocreatine pool after exercise using (31)P magnetic resonance spectroscopy can provide an in vivo m

129 tension imaging, functional MRI, and proton magnetic resonance spectroscopy, can detect non-focal, s

130 y data processing that is widely used in the magnetic resonance spectroscopy community and has evolve

131 of GSH levels in specific brain regions with magnetic resonance spectroscopy constitutes a clinically

132 ere we employed high-resolution (1)H nuclear magnetic resonance spectroscopy coupled with advanced mu

133 ion that facilitates common preprocessing of magnetic resonance spectroscopy data across multiple sca

134 tasets, and single volume diffusion-weighted magnetic resonance spectroscopy data from the anterior b

135 t relevant information needed for exchanging magnetic resonance spectroscopy data in digital form, as

136 way of documenting and exchanging processed magnetic resonance spectroscopy data in digital format.

137 jMRUI is a software tool for magnetic resonance spectroscopy data processing that is

138 -matched healthy control subjects (25 usable magnetic resonance spectroscopy data sets from the latte

139 n analysis on multicentre/multi-manufacturer magnetic resonance spectroscopy data.

140 an be a platform for outputting exchangeable magnetic resonance spectroscopy data.

141 Nuclear magnetic resonance spectroscopy demonstrated that the N-

142 Nuclear magnetic resonance spectroscopy demonstrates the intrins

143 volumes and function, whereas phosphorus-31 magnetic resonance spectroscopy evaluated ventricular en

144 Previous (13)C magnetic resonance spectroscopy experiments have shown t

145 vels at which circular dichroism and nuclear magnetic resonance spectroscopy fingerprinting, both gol

146 an electroencephalographic session for MMN, magnetic resonance spectroscopy for glutamate and GABA,

147 ontrast using T1 mapping, and (1)H and (31)P magnetic resonance spectroscopy for myocardial triglycer

148 ed by Nox1 deletion as determined by nuclear magnetic resonance spectroscopy, glucose tolerance tests

149 In recent years the field of nuclear magnetic resonance spectroscopy has advanced the way tha

150 ative metabolomics platform based on nuclear magnetic resonance spectroscopy has found widespread use

151 Magnetic resonance spectroscopy has shown the ability to

152 While X-ray crystallography and nuclear magnetic resonance spectroscopy have revealed the struct

153 functional MRI, diffusor tensor imaging, and magnetic resonance spectroscopy) have opened unprecedent

154 Hyperpolarized magnetic resonance spectroscopy (HP MRS) using dynamic n

155 spectrometry-solid-phase extraction-nuclear magnetic resonance spectroscopy (HR-bioassay/HPLC-HRMS-S

156 We quantified GlycA by 400 MHz (1)H nuclear magnetic resonance spectroscopy in 27,524 participants i

157 -center study (four centers), we used proton magnetic resonance spectroscopy in 51 children with ASD,

158 cingulate cortex (ACC) using 3-Tesla proton magnetic resonance spectroscopy in 75 participants at ul

159 2 gigapascals) boron-11 solid-state nuclear magnetic resonance spectroscopy in combination with ab i

160 We used magnetic resonance spectroscopy in humans, to measure le

161 tion of pulsed electrically detected nuclear magnetic resonance spectroscopy in organic light-emittin

162 We quantified liver fat percentage (%) by magnetic resonance spectroscopy in three liver zones.

163 Using hyperpolarized carbon-13 ((13)C)-magnetic resonance spectroscopy, in vivo alterations in

164 With the use of proton magnetic resonance spectroscopy, in vivo myocardial trig

165 sient HG bps, we used solution-state nuclear magnetic resonance spectroscopy, including measurements

166 absorption spectroscopy, solid-state nuclear magnetic resonance spectroscopy, infrared spectroscopy,

167 Nuclear magnetic resonance spectroscopy is a powerful tool for t

168 P transfer via CK, measured noninvasively by magnetic resonance spectroscopy, is an independent predi

169 f these species was characterized by nuclear magnetic resonance spectroscopy, mass spectrometry, X-ra

170 Magnetic resonance spectroscopy may be helpful in the di

171 GlycA is a novel proton nuclear magnetic resonance spectroscopy-measured biomarker of sy

172 Non-invasive (13)C magnetic resonance spectroscopy measurements of the upta

173 We use nuclear magnetic resonance spectroscopy methods to quantify the

174 ues used to study cerebral metabolism, (13)C magnetic resonance spectroscopy (MRS) allows following t

175 Magnetic resonance spectroscopy (MRS) allows for noninva

176 Hyperpolarization of substrates for magnetic resonance spectroscopy (MRS) and imaging (MRI)

177 In this study, we combined magnetic resonance spectroscopy (MRS) and resting state

178 sing two complementary methodologies, proton magnetic resonance spectroscopy (MRS) and tissue biochem

179 he role of magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS) and transrectal ul

180 y magnetic resonance imaging (MRI) and novel magnetic resonance spectroscopy (MRS) approaches.

181 Metabolite levels assessed by magnetic resonance spectroscopy (MRS) are used as marker

182 l magnetic resonance imaging (fMRI) and (1)H magnetic resonance spectroscopy (MRS) data were obtained

183 is metabolite to malate as detected by (13)C-magnetic resonance spectroscopy (MRS) has been suggested

184 Hyperpolarized (HP) (13)C magnetic resonance spectroscopy (MRS) has the unique abi

185 hizophrenia measuring total tissue GABA with magnetic resonance spectroscopy (MRS) have been inconsis

186 line and offline protocol combining tDCS and magnetic resonance spectroscopy (MRS) in 17 healthy part

187 f our study was to describe the role of (1)H magnetic resonance spectroscopy (MRS) in demonstrating t

188 (31)P magnetic resonance spectroscopy (MRS) is widely used for

189 recruited and underwent neurological exams, magnetic resonance spectroscopy (MRS) measurements, and

190 Magnetic resonance spectroscopy (MRS) measures of glutam

191 of lactate production, as determined by 13C magnetic resonance spectroscopy (MRS) of hyperpolarized

192 Purpose Proton magnetic resonance spectroscopy (MRS) of the brain can d

193 Hyperpolarized (13)C magnetic resonance spectroscopy (MRS) provides unprecede

194 Magnetic resonance spectroscopy (MRS) showed alterations

195 We applied the novel (17)O magnetic resonance spectroscopy (MRS) technique on R6/2

196 This study used high-field proton magnetic resonance spectroscopy (MRS) to determine wheth

197 resonance imaging (fMRI) with resting-state magnetic resonance spectroscopy (MRS) to measure task-re

198 We assessed whether Glu measured with magnetic resonance spectroscopy (MRS) was associated wit

199 Single-voxel magnetic resonance spectroscopy (MRS) was employed to me

200 Proton magnetic resonance spectroscopy (MRS) was used to test t

201 (1)H magnetic resonance spectroscopy (MRS) yields site-specif

202 sessed by electroretinography, brain MRI and magnetic resonance spectroscopy (MRS), and electron micr

203 hearts, energetics were measured using (31)P magnetic resonance spectroscopy (MRS), and glycolysis an

204 nerve fibers, and underwent muscle and brain magnetic resonance spectroscopy (MRS), and muscle biopsy

205 By using (31)P magnetic resonance spectroscopy (MRS), we demonstrated t

206 c resonance imaging (fMRI) and resting-state magnetic resonance spectroscopy (MRS).

207 try and high resolution magic angle spinning magnetic resonance spectroscopy (MRS).

208 erior cingulate cortex (dACC) as measured by magnetic resonance spectroscopy (MRS).

209 llar white matter, and elevated succinate on magnetic resonance spectroscopy (MRS).

210 d by diffusion tensor imaging (DTI) and (1)H magnetic resonance spectroscopy (MRS).

211 -NP) in ApoE null mouse plaques with [(19)F] magnetic resonance spectroscopy (MRS).

212 as age-matched healthy control subjects with magnetic resonance spectroscopy (MRS).

213 e pool size assayed via high-resolution (1)H magnetic resonance spectroscopy (MRS).

214 of N-acetylaspartate to creatinine levels (a magnetic resonance spectroscopy neuronal integrity bioma

215 Using (1)H Nuclear Magnetic Resonance spectroscopy (NMR) and Gas Chromatogr

216 Liquid-state, one-dimension (31)P nuclear magnetic resonance spectroscopy (NMR) has greatly advanc

217 u by activated recombinant ERK2 with nuclear magnetic resonance spectroscopy (NMR) reveals phosphoryl

218 Furthermore, we hypothesized that nuclear magnetic resonance spectroscopy (NMR) would measure such

219 ting oligomers were characterized by nuclear magnetic resonance spectroscopy (NMR), cyclic voltammetr

220 tty acid methyl esters (FAMEs), (1)H nuclear magnetic resonance spectroscopy (NMR), employing a 700 M

221 mass spectrometry (MS) and 1D and 2D nuclear magnetic resonance spectroscopy (NMR).

222 graphy mass spectrometry (GC-MS) and nuclear magnetic resonance spectroscopy (NMR).

223 didate biomarkers were quantified by nuclear magnetic resonance spectroscopy of non-fasting plasma sa

224 Nuclear magnetic resonance spectroscopy of products from the cop

225 design and structural validation by nuclear magnetic resonance spectroscopy of the first stable, bio

226 nsulin clamp with muscle biopsy, and 3) (1)H-magnetic resonance spectroscopy of tibialis anterior mus

227 reanalyzed extensive measurements from (13)C magnetic resonance spectroscopy of yeast glycolysis and

228 thyl transverse relaxation-optimized nuclear magnetic resonance spectroscopy on a 450-kilodalton comp

229 domain of an adenine riboswitch for nuclear magnetic resonance spectroscopy or single-molecule Forst

230 vivo human livers, we compared MRI-PDFF with magnetic resonance spectroscopy-PDFF (MRS-PDFF), biochem

231 ts main characteristics are: 1) it automates magnetic resonance spectroscopy preprocessing, and 2) it

232 (31)P magnetic resonance spectroscopy provides a noninvasive w

233 Magnetic resonance spectroscopy provides metabolic infor

234 rdiopulmonary exercise test and a phosphorus magnetic resonance spectroscopy quadriceps muscle exerci

235 Here we studied, mainly by nuclear magnetic resonance spectroscopy, residual secondary stru

236 Fluorescence and Proton nuclear magnetic resonance spectroscopy results showed near 100%

237 esolution mass spectrometry (MS) and nuclear magnetic resonance spectroscopy reveal abundant nitrogen

238 Cerebral proton magnetic resonance spectroscopy revealed an abnormal lip

239 In vivo (1)H-magnetic resonance spectroscopy revealed an age-dependen

240 ion to wood over a time course using nuclear magnetic resonance spectroscopy revealed diurnal pattern

241 (1)H magnetic resonance spectroscopy revealed that greater re

242 ombination of X-ray crystallography, nuclear magnetic resonance spectroscopy, SAXS and molecular dyna

243 Following baseline proton magnetic resonance spectroscopy scans targeting the mPFC

244 groups were brought back to undergo outcome magnetic resonance spectroscopy scans, which were identi

245 Search terms included magnetic resonance spectroscopy, schizophrenia, psychosi

246 ) and of denatured proteins based on nuclear magnetic resonance spectroscopy, small-angle X-ray scatt

247 Nuclear magnetic resonance spectroscopy studies and density func

248 Here, we conducted a series of proton magnetic resonance spectroscopy studies in human volunte

249 The mutation, as indicated by nuclear magnetic resonance spectroscopy studies, alters the prot

250 goal of achieving better transferability of magnetic resonance spectroscopy studies.

251 esent study employed state-of-the-art proton magnetic resonance spectroscopy techniques to measure ch

252 Here we show by nuclear magnetic resonance spectroscopy that inhibitors of LpxC-

253 Here, we demonstrate by nuclear magnetic resonance spectroscopy that the Escherichia col

254 We used nuclear magnetic resonance spectroscopy to address these issues.

255 roduced multidimensional solid-state nuclear magnetic resonance spectroscopy to characterize the spat

256 m (2)H, (13)C, and (31)P solid-state nuclear magnetic resonance spectroscopy to decipher the hydropho

257 ng solubility enhancement as well as nuclear magnetic resonance spectroscopy to demonstrate solution-

258 trate the ability of hyperpolarized pyruvate magnetic resonance spectroscopy to detect metformin-indu

259 We used hyperpolarized [1-(13)C]pyruvate magnetic resonance spectroscopy to determine the effects

260 Here, we use (31)P nuclear magnetic resonance spectroscopy to determine the speciat

261 We use solution nuclear magnetic resonance spectroscopy to directly probe the dy

262 We used proton magnetic resonance spectroscopy to examine myo-Inositol

263 Here, we use solid-state nuclear magnetic resonance spectroscopy to gain atomic level ins

264 We used ultra-high-field (7 T) magnetic resonance spectroscopy to investigate in vivo c

265 ery and neuroimaging that included optimized magnetic resonance spectroscopy to measure anterior cing

266 the Dallas Heart Study also underwent proton magnetic resonance spectroscopy to measure hepatic trigl

267 We used 1.5T magnetic resonance spectroscopy to measure prefrontal N-

268 We used pulmonary gas exchange and (31) P magnetic resonance spectroscopy to measure whole-body VO

269 Here, we used magnetic resonance spectroscopy to non-invasively quanti

270 Our goal was to use (13)C magnetic resonance spectroscopy to probe the conversion

271 dults (N = 48; age range, 50-79 years) using magnetic resonance spectroscopy to quantify GABA levels

272 re we demonstrate the application of nuclear magnetic resonance spectroscopy to study the structure a

273 clear polarization-based solid-state nuclear magnetic resonance spectroscopy to validate a structural

274 innovative application of (13)C NMR (nuclear magnetic resonance) spectroscopy to determine the bulk (

275 cortex was measured by (1)H-[(13)C]-nuclear magnetic resonance spectroscopy together with infusion o

276 metabolism, we performed phosphorous ((31)P) magnetic resonance spectroscopy using a 1.5-Tesla system

277 c content measured in lymphocytes by nuclear magnetic resonance spectroscopy was altered in septic pa

278 Nuclear Magnetic Resonance spectroscopy was employed to study th

279 BP688 was used to measure mGluR5 binding and magnetic resonance spectroscopy was used to measure glut

280 of Escherichia coli H69 in solution, nuclear magnetic resonance spectroscopy was used to reveal the s

281 Liver fat content (proton magnetic resonance spectroscopy) was measured in 378 sub

282 Finally, using in vivo proton magnetic resonance spectroscopy we found tissue signatur

283 Using Nuclear Magnetic Resonance spectroscopy we reveal how disease-ca

284 Using nuclear magnetic resonance spectroscopy, we characterized sparti

285 Then, using magnetic resonance spectroscopy, we demonstrate a tight

286 Using nuclear magnetic resonance spectroscopy, we demonstrate in the p

287 Using nuclear magnetic resonance spectroscopy, we first show that expo

288 Using time-resolved nuclear magnetic resonance spectroscopy, we found that ERK2 phos

289 Using nuclear magnetic resonance spectroscopy, we identified an additi

290 -labeling strategy in combination with (13)C magnetic resonance spectroscopy, we show that rates of m

291 monary gas-exchange and intramuscular (31) P magnetic resonance spectroscopy, we tested the hypothese

292 r, molecular phenotypes, neuropathology, and magnetic resonance spectroscopy were done on all groups,

293 late gadolinium enhancement [LGE]), and (1)H magnetic resonance spectroscopy were performed.

294 njunction with mass spectrometry and nuclear magnetic resonance spectroscopy were used for the struct

295 antar flexion exercise fatigability test and magnetic resonance spectroscopy were used to probe the m

296 FMRI data and GABA levels, as assessed by Magnetic Resonance Spectroscopy, were measured before an

297 IgE and IgA paratopes were probed by nuclear magnetic resonance spectroscopy with (15)N-labeled pepti

298 te-cycled, non-water suppressed (1)H cardiac magnetic resonance spectroscopy with prospective and ret

299 (7)Li, (19)F, and (13)C solid-state nuclear magnetic resonance spectroscopies, with the organics dom

300 ine recovery time constant (tauPCr) by (31)P-magnetic resonance spectroscopy, with higher tauPCr valu